Screening and Treatment of Adenovirus Infection in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: Multicenter Survey of Transplant Centers in the United States
Genovefa A. Papanicolaou(Memorial Sloan Kettering Cancer Center), Christopher C. Dvorak(University of California, San Francisco), Sanjeet Dadwal(City Of Hope National Medical Center), Essy Mozaffari(Gilead Sciences (United States)), Robert H. Hutcheson, Gabriela Marón(St. Jude Children's Research Hospital), Sonali Chaudhury(Northwestern University), Aastha Chandak(University of Nebraska Medical Center), Garrett Nichols(Chimerix (United States)), Thomas M. Brundage(Chimerix (United States)), Enrikas Vainorius(Chimerix (United States))
Cited by 0
Related Papers
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
|Clinical Infectious Diseases|2021|299
Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
|Transplantation and Cellular Therapy|2013|248
Use of Mobile Health Applications for Health-Seeking Behavior Among US Adults
|Journal of Medical Systems|2016|220
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses
|Cell Reports Medicine|2021|219